#phase3studies — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #phase3studies, aggregated by home.social.
-
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
Sanofi Winthrop Industrie Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP …
#France #FR #Europe #EU #Sanofi #AmericanAcademyofNeurology #clinicalstudy #cognitiveimpairment #EuropeanMedicinesAgency #liverenzymeelevations #phase3studies #progressivemultiplesclerosis #tolebrutinib
https://www.europesays.com/france/18870/